Sign in to view content

Defining a 'Strong' and 'Weak' Response to Anti-VEGF Treatment CI-DME: Retrospective Analysis of 3 DRCR Retina Network Clinical Trials

Sharon D. Solomon, MD

Video
Published 2023

Related

Primary Results for Protocol AB
Andrew N. Antoszyk, MD FASRS
Updates from the Field
2020
Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy
Andrew N. Antoszyk, MD FASRS
Updates from the Field
2016
Clinical Feasibility of Ultra-rapid, Non-pharmacologic Anesthesia for Intravitreal Injection in Patients Receiving Anti-VEGF Treatment
Cagri G Besirli, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

Anti-VEGF

See more